Blight study definition

Blight study means a study to determine the existence or nonexistence of blight
Sample 1Sample 2Sample 3
Blight study means a study to determine whether blight exists within a survey
Sample 1Sample 2Sample 3
Blight study means a study to determine whether blight exists within a survey area as described in Section 17C-2-301 for an urban renewal project area or Section 17C-5-403 for a community reinvestment project area.
Sample 1Sample 2Sample 3

Examples of Blight study in a sentence

  • University furniture may not be removed from University housing at any time, including placement on patios or balconies.

  • She stated that she thinks the Blight study could go hand in hand with the plan.

  • A-5402; see also No Blight study at 50-51, RA-1333-1334; see infra notes 217-218.

  • August 2004 photographs from AKRF’s Architectural Resources Survey of August 2004, RA-555-558; No Blight study, RA-1312; see also Comment of Walter South at September 30, 2006 public meeting of the West Harlem LDC, RA-545.

  • Petitioners-Respondents, through their own No Blight study, have been able to document not only that the area is not blighted, but that ESDC’s consultants implemented an intentionally biased methodology, whereby they could find allegedly substandard conditions on the basis of 76% of the properties that were under Columbia’s control, without accounting for Columbia’s direct impacts in vacating and running down the property.

  • AKRF Atlantic Yards Blight study at C-5, RA-1115, with AKRF Manahttanville Neighborhood Conditions Study at ii, A-3354.

  • See, AKRF study at viii, A- 3360; AKRF Figure 2, A-3353 (noting Block 1999, Lot 29 as 25% or more vacant).174 See AKRF study at A-3354, A-3360 - A-3361.175 See Leitner Group, Manhattanville Market Study, at 29- 36, RA-1752-1759.176 See No Blight study at 32-34, RA-1312-1314.177 AKRF also did not show any tax delinquency in the area, or any other evidence of burden upon public services.

  • For a count of Columbia ownership or control in any given year, see No Blight study, Table I, RA-1364-1369.

  • Building permit records indicate no building permits have been issued for new fire suppression systems for buildings with the study area since the original Blight study was performed.

  • Their Blight study in 2005 , indicates that 94 percent of the 171 parcels are blighted and recommended demolishing 66 buildings of 72.


More Definitions of Blight study

Blight study means a study to determine the existence or nonexistence of blight within a survey area as provided in Section 17C-2-301.
Sample 1Sample 2Sample 3
Blight study means a study to determine [the existence or nonexistence of 929 blight] whether blight exists within a survey area as [provided] described in Section 17C-2-301 930 for an urban renewal project area or Section 17C-5-403 for a community reinvestment project 931 area.
Sample 1Sample 2
Blight study means a study to determine the existence or nonexistence of blight within a survey area as provided in Section 17B-4-602.
Sample 1Sample 2Sample 3
Blight study means a study to determine the existence or nonexistence of 636 blight within a survey area as provided in Section [17B-4-602] 17C-2-301.
Sample 1Sample 2

Related to Blight study

  • System Impact Study means an assessment by the Transmission Provider of (i) the adequacy of the Transmission System to accommodate a Completed Application, an Interconnection Request or an Upgrade Request, (ii) whether any additional costs may be incurred in order to provide such transmission service or to accommodate an Interconnection Request, and (iii) with respect to an Interconnection Request, an estimated date that an Interconnection Customer’s Customer Facility can be interconnected with the Transmission System and an estimate of the Interconnection Customer’s cost responsibility for the interconnection; and (iv) with respect to an Upgrade Request, the estimated cost of the requested system upgrades or expansion, or of the cost of the system upgrades or expansion, necessary to provide the requested incremental rights. System Protection Facilities: “System Protection Facilities” shall refer to the equipment required to protect (i) the Transmission System, other delivery systems and/or other generating systems connected to the Transmission System from faults or other electrical disturbance occurring at or on the Customer Facility, and (ii) the Customer Facility from faults or other electrical system disturbance occurring on the Transmission System or on other delivery systems and/or other generating systems to which the Transmission System is directly or indirectly connected. System Protection Facilities shall include such protective and regulating devices as are identified in the Applicable Technical Requirements and Standards or that are required by Applicable Laws and Regulations or other Applicable Standards, or as are otherwise necessary to protect personnel and equipment and to minimize deleterious effects to the Transmission System arising from the Customer Facility. Transmission Facilities:

  • Phase 3 Study means a clinical study of an investigational product in patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Marketing Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable Clinical Study prescribed by the relevant Regulatory Authority in a country other than the United States. The investigational product can be administered to patients as a single agent or in combination with other investigational or marketed agents and a Phase 3 Study shall be deemed commenced when Initiated.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Home study means the assessment process used for the purpose of determining the ability of an applicant to care for a child in need of foster care placement.

  • Pivotal Trial means a clinical study in humans of the efficacy and safety of a Licensed Product that is prospectively designed to demonstrate with statistical significance that such product is effective and safe for use in a particular indication in a manner sufficient to file for Marketing Approval of such product and would satisfy the requirements of 21 CFR 312.21(c), or a similar clinical study prescribed by the Regulatory Authorities in a country other than the United States.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Feasibility Study means the evaluation and analysis of the potential of a project, which aims at supporting the process of decision-making by objectively and rationally uncovering its strengths and weaknesses, opportunities and threats, as well as identifying the resources required to carry it through and ultimately its prospects for success;

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).

  • Integrated Development Plan means a plan formulated and approved as envisaged in Section 25 of the Municipal Systems Act 2000, as amended.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.